SciSparc Ltd. (SPRC)
0.32
-0.00 (-1.27%)
At close: Mar 25, 2025, 3:59 PM
0.32
-0.28%
Pre-market: Mar 26, 2025, 07:02 AM EDT
-1.27% (1D)
| Bid | 0.3 |
| Market Cap | 3.51M |
| Revenue (ttm) | 9.34M |
| Net Income (ttm) | -30.4M |
| EPS (ttm) | -5.28 |
| PE Ratio (ttm) | -0.06 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.33 |
| Volume | 199,021 |
| Avg. Volume (20D) | 10,670,245 |
| Open | 0.32 |
| Previous Close | 0.32 |
| Day's Range | 0.32 - 0.34 |
| 52-Week Range | 0.20 - 2.10 |
| Beta | 0.80 |
About SPRC
SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The company has an agreement with Procaps to develop and commercially manufactur...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 30, 2021
Employees 3
Stock Exchange NASDAQ
Ticker Symbol SPRC
Website https://scisparc.com
2 weeks ago
+25.16%
SciSparc shares are trading higher after announcin...
Unlock content with
Pro Subscription
2 months ago
+102.69%
SciSparc and Clearmind Medicine shares are trading higher after announcing the publication of a European patent application for binge behavior.
